Small Maf proteins heterodimerize with Fos and may act as competitive repressors of the NF-E2 transcription factor - PubMed (original) (raw)

Comparative Study

Small Maf proteins heterodimerize with Fos and may act as competitive repressors of the NF-E2 transcription factor

K Kataoka et al. Mol Cell Biol. 1995 Apr.

Erratum in

• Mol Cell Biol 1995 Jun;15(6):3461

Abstract

The maf oncogene encodes a bZip nuclear protein which recognizes sequences related to an AP-1 site either as a homodimer or as heterodimers with Fos and Jun. We describe here a novel maf-related gene, mafG, which shows extensive homology with two other maf-related genes, mafK and mafF. These three maf-related genes encode small basic-leucine zipper proteins lacking the trans-activator domain of v-Maf. Bacterially expressed small Maf proteins bind to DNA as homodimers with a sequence recognition profile that is virtually identical to that of v-Maf. As we have previously described, the three small Maf proteins also dimerize with the large subunit of NF-E2 (p45) to form an erythroid cell-specific transcription factor, NF-E2, which has distinct DNA-binding specificity. This study shows that the small Maf proteins can also dimerize among themselves and with Fos and a newly identified p45-related molecule (Ech) but not with v-Maf or Jun. Although the small Maf proteins preferentially recognize the consensus NF-E2 sequence as heterodimers with either NF-E2 p45, Ech, or Fos, these heterodimers seemed to be different in their transactivation potentials. Coexpression of Fos and small Mafs could not activate a promoter with tandem repeats of the NF-E2 site. These results raise the possibility that tissue-specific gene expression and differentiation of erythroid cells are regulated by competition among Fos, NF-E2 p45, and Ech for small Maf proteins and for binding sites.

PubMed Disclaimer

Similar articles

• Regulation of transcription by dimerization of erythroid factor NF-E2 p45 with small Maf proteins.
  Igarashi K, Kataoka K, Itoh K, Hayashi N, Nishizawa M, Yamamoto M. Igarashi K, et al. Nature. 1994 Feb 10;367(6463):568-72. doi: 10.1038/367568a0. Nature. 1994. PMID: 8107826
• Transactivation activity of Maf nuclear oncoprotein is modulated by Jun, Fos and small Maf proteins.
  Kataoka K, Noda M, Nishizawa M. Kataoka K, et al. Oncogene. 1996 Jan 4;12(1):53-62. Oncogene. 1996. PMID: 8552399
• Small Maf proteins interact with the human transcription factor TCF11/Nrf1/LCR-F1.
  Johnsen O, Skammelsrud N, Luna L, Nishizawa M, Prydz H, Kolstø AB. Johnsen O, et al. Nucleic Acids Res. 1996 Nov 1;24(21):4289-97. doi: 10.1093/nar/24.21.4289. Nucleic Acids Res. 1996. PMID: 8932385 Free PMC article.
• The world according to Maf.
  Motohashi H, Shavit JA, Igarashi K, Yamamoto M, Engel JD. Motohashi H, et al. Nucleic Acids Res. 1997 Aug 1;25(15):2953-59. doi: 10.1093/nar/25.15.2953. Nucleic Acids Res. 1997. PMID: 9224592 Free PMC article. Review.
• Integration and diversity of the regulatory network composed of Maf and CNC families of transcription factors.
  Motohashi H, O'Connor T, Katsuoka F, Engel JD, Yamamoto M. Motohashi H, et al. Gene. 2002 Jul 10;294(1-2):1-12. doi: 10.1016/s0378-1119(02)00788-6. Gene. 2002. PMID: 12234662 Review.

Cited by

• The Role of Nrf2 in Hearing Loss.
  Li D, Zhao H, Cui ZK, Tian G. Li D, et al. Front Pharmacol. 2021 Apr 12;12:620921. doi: 10.3389/fphar.2021.620921. eCollection 2021. Front Pharmacol. 2021. PMID: 33912042 Free PMC article. Review.
• MafF Is an Antiviral Host Factor That Suppresses Transcription from Hepatitis B Virus Core Promoter.
  Ibrahim MK, Abdelhafez TH, Takeuchi JS, Wakae K, Sugiyama M, Tsuge M, Ito M, Watashi K, El Kassas M, Kato T, Murayama A, Suzuki T, Chayama K, Shimotohno K, Muramatsu M, Aly HH, Wakita T. Ibrahim MK, et al. J Virol. 2021 Jul 12;95(15):e0076721. doi: 10.1128/JVI.00767-21. Epub 2021 Jul 12. J Virol. 2021. PMID: 33980595 Free PMC article.
• MAFG-driven osteosarcoma cell progression is inhibited by a novel miRNA miR-4660.
  Shan HJ, Zhu LQ, Yao C, Zhang ZQ, Liu YY, Jiang Q, Zhou XZ, Wang XD, Cao C. Shan HJ, et al. Mol Ther Nucleic Acids. 2021 Mar 13;24:385-402. doi: 10.1016/j.omtn.2021.03.006. eCollection 2021 Jun 4. Mol Ther Nucleic Acids. 2021. PMID: 33868783 Free PMC article.
• Structural basis of alternative DNA recognition by Maf transcription factors.
  Kurokawa H, Motohashi H, Sueno S, Kimura M, Takagawa H, Kanno Y, Yamamoto M, Tanaka T. Kurokawa H, et al. Mol Cell Biol. 2009 Dec;29(23):6232-44. doi: 10.1128/MCB.00708-09. Epub 2009 Sep 21. Mol Cell Biol. 2009. PMID: 19797082 Free PMC article.
• Heme mediates derepression of Maf recognition element through direct binding to transcription repressor Bach1.
  Ogawa K, Sun J, Taketani S, Nakajima O, Nishitani C, Sassa S, Hayashi N, Yamamoto M, Shibahara S, Fujita H, Igarashi K. Ogawa K, et al. EMBO J. 2001 Jun 1;20(11):2835-43. doi: 10.1093/emboj/20.11.2835. EMBO J. 2001. PMID: 11387216 Free PMC article.

References

1. 1. Adv Cancer Res. 1990;55:37-55 - PubMed
2. 1. Proc Natl Acad Sci U S A. 1993 Dec 1;90(23):11371-5 - PubMed
3. 1. Blood. 1990 Nov 1;76(9):1830-7 - PubMed
4. 1. Genes Dev. 1990 Oct;4(10):1650-62 - PubMed
5. 1. J Biol Chem. 1990 Dec 25;265(36):22090-2 - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Atypon
  • Europe PubMed Central
  • PubMed Central
  • Taylor & Francis

• Other Literature Sources

  • The Lens - Patent Citations Database

• Research Materials

  • NCI CPTC Antibody Characterization Program

• Miscellaneous

  • NCI CPTAC Assay Portal